About us

The Christie is one of Europe's experimental cancer medicine centres and an international leader in research and development.

Through generous funding, we continue to support early-phase clinical trials and other leading research projects. Among our largest partners are the National Institute for Health Research (NIHR) and Cancer Research UK.

Our Research and Development Division was formed in January 2008 and employs dedicated research staff, including research nurses, clinical trial coordination staff and the core research and development team.

Research and Development is embedded within each service department across the trust and all of these departments support patients participating in clinical trials.

Our research portfolio includes a wide range of treatment and non-treatment trials across all phases. This ground-breaking research is made possible through the support of university facilities and our on-site research facility.

The Christie has one of the largest trials portfolios in the UK, with more than 550 active clinical trials over the full range of adult and teenage cancers.


According to recent figures from the European Organisation for Research and Treatment of Cancer (EORTC), doctors at The Christie recruited the largest number of patients between 2011 and 2013 in clinical trials of radiation-based therapies.

The Christie NHS Foundation Trust is currently second in the league table of NHS providers, based on the number of studies delivered.

The Christie currently has the most open studies in Greater Manchester, and is one of the highest recruiting cancer network in the UK. 

Around one in five patients who visited the trust in 2013/14 as an outpatient had taken part in research at some point during their time as a Christie patient.

Also 20 per cent of patients who have consented to research have been involved in more than one study at The Christie. 

 


;